TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2015

Belinostat in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results of the Pivotal Phase II BELIEF (CLN-19) Study.

Owen A O'Connor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.